These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35115301)

  • 41. Prognosis of ovarian cancer in women with type 2 diabetes using metformin and other forms of antidiabetic medication or statins: a retrospective cohort study.
    Urpilainen E; Marttila M; Hautakoski A; Arffman M; Sund R; Ilanne-Parikka P; Arima R; Kangaskokko J; Puistola U; Hinkula M; Läärä E
    BMC Cancer; 2018 Jul; 18(1):767. PubMed ID: 30055585
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Real-world treatment escalation from metformin monotherapy in youth-onset Type 2 diabetes mellitus: A retrospective cohort study.
    Vajravelu ME; Hitt TA; Amaral S; Levitt Katz LE; Lee JM; Kelly A
    Pediatr Diabetes; 2021 Sep; 22(6):861-871. PubMed ID: 33978986
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Six-Year Incidence and Progression of Age-Related Macular Degeneration in Kenya: Nakuru Eye Disease Cohort Study.
    Bastawrous A; Mathenge W; Peto T; Shah N; Wing K; Rono H; Weiss HA; Macleod D; Foster A; Burton M; Kuper H
    JAMA Ophthalmol; 2017 Jun; 135(6):631-638. PubMed ID: 28494075
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Association of Metformin, Other Antidiabetic Medications and Statins on the Prognosis of Rectal Cancer in Patients with Type 2 Diabetes: A Retrospective Cohort Study.
    Erkinantti S; Hautakoski A; Sund R; Arffman M; Urpilainen E; Puistola U; Läärä E; Jukkola A; Karihtala P
    Biomolecules; 2022 Sep; 12(9):. PubMed ID: 36139140
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Risk of TB in Patients With Type 2 Diabetes Initiating Metformin vs Sulfonylurea Treatment.
    Pan SW; Yen YF; Kou YR; Chuang PH; Su VY; Feng JY; Chan YJ; Su WJ
    Chest; 2018 Jun; 153(6):1347-1357. PubMed ID: 29253553
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development of heart failure in Medicaid patients with type 2 diabetes treated with pioglitazone, rosiglitazone, or metformin.
    Breunig IM; Shaya FT; McPherson ML; Snitker S
    J Manag Care Spec Pharm; 2014 Sep; 20(9):895-903. PubMed ID: 25166288
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mortality among veterans with type 2 diabetes initiating metformin, sulfonylurea or rosiglitazone monotherapy.
    Wheeler S; Moore K; Forsberg CW; Riley K; Floyd JS; Smith NL; Boyko EJ
    Diabetologia; 2013 Sep; 56(9):1934-43. PubMed ID: 23797633
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Metformin and the risk of prostate cancer across racial/ethnic groups: a population-based cohort study.
    Chen CB; Eurich DT; Majumdar SR; Johnson JA
    Prostate Cancer Prostatic Dis; 2017 Mar; 20(1):122-126. PubMed ID: 28071672
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dose-response association of metformin use and risk of age-related macular degeneration among patients with type 2 diabetes mellitus: a population-based study.
    Huang KH; Chang YL; Lee CB; Gau SY; Tsai TH; Chung NJ; Lee CY
    Front Pharmacol; 2023; 14():1275095. PubMed ID: 38074151
    [No Abstract]   [Full Text] [Related]  

  • 50. Incidence of metformin use in patients with age-related macular degeneration versus normal controls: A population-based study in Olmsted County, Minnesota.
    Starr MR; Dalvin LA; AbouChehade JE; Damento GM; Garcia M; Shah SM; Hodge DO; Iezzi R; Bakri SJ
    Eye (Lond); 2023 Jun; 37(9):1861-1865. PubMed ID: 36151313
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Risk of incident dementia following metformin initiation compared with noninitiation or delay of antidiabetic medication therapy.
    Salas J; Morley JE; Scherrer JF; Floyd JS; Farr SA; Zubatsky M; Barthold D; Dublin S
    Pharmacoepidemiol Drug Saf; 2020 Jun; 29(6):623-634. PubMed ID: 32363681
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Incidence of and Risk Factors Associated With Age-Related Macular Degeneration: Four-Year Follow-up From the ALIENOR Study.
    Saunier V; Merle BMJ; Delyfer MN; Cougnard-Grégoire A; Rougier MB; Amouyel P; Lambert JC; Dartigues JF; Korobelnik JF; Delcourt C
    JAMA Ophthalmol; 2018 May; 136(5):473-481. PubMed ID: 29596588
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development of Osteoarthritis in Adults With Type 2 Diabetes Treated With Metformin vs a Sulfonylurea.
    Baker MC; Sheth K; Liu Y; Lu D; Lu R; Robinson WH
    JAMA Netw Open; 2023 Mar; 6(3):e233646. PubMed ID: 36939700
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association Between Antidiabetic Medications and Prostate-Specific Antigen Levels and Biopsy Results.
    Beckmann K; Crawley D; Nordström T; Aly M; Olsson H; Lantz A; Binti Abd Jalal N; Garmo H; Adolfsson J; Eklund M; Van Hemelrijck M
    JAMA Netw Open; 2019 Nov; 2(11):e1914689. PubMed ID: 31693126
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Increased Risk of Age-Related Macular Degeneration with Chronic Hepatitis C Virus Infection: A Nationwide Population-Based Propensity Score-Matched Cohort Study in Taiwan.
    Yeh CC; Wu MM; Wu CM; Sung FC; Muo CH; Te A; Su FH
    Viruses; 2021 Apr; 13(5):. PubMed ID: 33925141
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative effectiveness of sulfonylurea and metformin monotherapy on cardiovascular events in type 2 diabetes mellitus: a cohort study.
    Roumie CL; Hung AM; Greevy RA; Grijalva CG; Liu X; Murff HJ; Elasy TA; Griffin MR
    Ann Intern Med; 2012 Nov; 157(9):601-10. PubMed ID: 23128859
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of metformin exposure on neurodegenerative diseases in elderly patients with type 2 diabetes mellitus.
    Kuan YC; Huang KW; Lin CL; Hu CJ; Kao CH
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):77-83. PubMed ID: 28583443
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antidiabetic drugs and heart failure risk in patients with type 2 diabetes in the U.K. primary care setting.
    Maru S; Koch GG; Stender M; Clark D; Gibowski L; Petri H; White AD; Simpson RJ
    Diabetes Care; 2005 Jan; 28(1):20-6. PubMed ID: 15616228
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Metformin reduces the risk of cancer in patients with type 2 diabetes: An analysis based on the Korean National Diabetes Program Cohort.
    Kim HJ; Lee S; Chun KH; Jeon JY; Han SJ; Kim DJ; Kim YS; Woo JT; Nam MS; Baik SH; Ahn KJ; Lee KW
    Medicine (Baltimore); 2018 Feb; 97(8):e0036. PubMed ID: 29465545
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Metformin use and risk of colorectal adenoma after polypectomy in patients with type 2 diabetes mellitus.
    Marks AR; Pietrofesa RA; Jensen CD; Zebrowski A; Corley DA; Doubeni CA
    Cancer Epidemiol Biomarkers Prev; 2015 Nov; 24(11):1692-8. PubMed ID: 26377195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.